Aims/hypothesis. Risk scores have been developed to predict cardiovascular or coronary risk, and while most have included diabetes as a risk factor, none have included lower glucose concentrations, either at fasting or following a 2-h oral glucose tolerance test. This article develops 5-and 10-year risk scores for cardiovascular mortality that include glucose concentrations as well as known diabetes status. Methods. Data is from the DECODE cohort: 16,506 men and 8,907 women from 14 European studies. The risk factors studied were as follows: age, fasting and 2-h glucose (including cases of known diabetes), fasting glucose alone (including cases of known diabetes), cholesterol, smoking status, systolic blood pressure and BMI. For an absolute risk score the 1995 countryand sex-specific cardiovascular death rates were used. Results. In men, for both 5-and 10-year cardiovascular mortality, after adjusting for age and study centre, all studied risk factors, except BMI, were significantly associated with cardiovascular mortality (p<0.05). These results were unchanged in multivariate models with all factors included. In women, after adjusting for age and centre, glucose categories, systolic blood pressure and BMI were predictive of 5-year cardiovascular mortality. With all factors in the model, only age and glucose categories were predictive. In terms of 10-year cardiovascular mortality, smoking status and blood pressures were also predictive in the women. For men and women, the same scores were used for the risk factors, except for age and glucose categories where the hazard ratios differed significantly. Conclusions/interpretation. Including glucose concentrations as well as diabetic status provides quantitative information on cardiovascular risk prediction.
Introduction
The prevention of cardiovascular diseases is now targeted for the reduction of the overall absolute risk of the disease [1, 2, 3, 4] , taking into account a number of risk factors. Various risk scores have been developed to estimate the risk of a coronary or a cardiovascular event (or mortality) within a given time frame in those without cardiovascular disease at baseline. The original risk scores were developed from the Framingham Study and they have been updated several times [5, 6, 7, 8] . The first score included the major risk factors that had been identified at the time: sex, age, systolic blood pressure, total cholesterol, cigarette use, diabetes and left ventricular hypertrophy (from an * only in subjects not known as diabetic ECG) [5] . The most recent score from the Framingham Study [8] used age, categories of blood pressure, cigarette use, total and HDL cholesterol, and diabetes. A number of other authors have also developed scores or predictions for cardiovascular morbidity or mortality [9, 10, 11, 12, 13, 14, 15, 16] . In 2003 the European SCORE project published their risk score based on pooled data from more than 200,000 men and women [1, 17] . The Framingham and other risk scores have been tested in different populations [11, 15, 18, 19, 20, 21, 22, 23, 24] . The general conclusion from the comparative studies is that while the absolute risk may differ from population to population, the risk ranking provided by these scores is consistent over populations. Diabetes has long been recognised as a major cardiovascular risk factor, and diabetic subjects have a risk of early death, in particular from cardiovascular disease, that is at least two times higher than that of subjects with normal glucose concentrations [25, 26] . Diabetic status has been included in almost all risk equations, although in the SCORE project it was not included as it was not uniformly collected in the participating studies. Results from a number of cohort studies, in particular from the DECODE Study, indicate that glucose concentrations, both fasting and 2 h post-challenge, that are below the threshold levels used for the diagnosis of diabetes are also risk factors for cardiovascular mortality [25, 26, 27, 28, 29, 30, 31] .
We used the large European DECODE cohort to develop risk scores for cardiovascular mortality over 5-year and 10-year follow-up periods. In addition to the classical cardiovascular risk factors we included glucose concentrations and known diabetic status in this score. We developed a score for absolute risk based on country-specific cardiovascular disease death rates for 1995.
Subjects and methods
Study population. The methods used to recruit the participants in the DECODE Study have been reported in our previous publications [25, 26, 31] . Briefly, data on mortality from population-based studies or large studies in occupational groups in Europe, that included glucose concentrations at fasting and 2 h after a 75-g OGTT, were collated and analysed in the Diabetes and Genetic Epidemiology Unit of the National Public Health Institute in Helsinki, Finland.
A total of 14 cohorts provided data on cardiovascular mortality and on the following cardiovascular risk factors: age, smoking habits, arterial blood pressures, total cholesterol concentration and BMI as well as fasting and 2-h glucose concentrations and diabetic status. Other risk factors such as HDL cholesterol, triglycerides and waist circumference were not available in all of the cohorts. Subjects were followed up over a minimum of 4.8 years for mortality, and a number of studies had more than 10 years of follow-up.
Ethical standards relevant at the time of the studies were adhered to.
Vital status. Vital status was followed up in the subjects who attended the baseline examination. Subjects who emigrated, for whom vital status could not be confirmed, were censored at the time of emigration. The follow-up was almost complete, from 95% in the Paris Prospective Study to 100% in most of the other studies, and the maximum length of follow-up for each study is given in Table 1 .
Fatal events were classified using the International Classification of Diseases: cardiovascular diseases were defined by codes 401 to 448 of the Eighth or Ninth Revisions and codes I10 to I79 for the Tenth Revision [32, 33] . Causes of death were obtained from death certificates or were arbitrated by an independent medical panel.
Statistical analysis. Before analysis, if glucose concentrations were not measured in plasma, they were transformed into plasma glucose concentrations, as already documented in other DECODE Study publications [34] . Subjects were classified according to age, fasting and 2-h plasma glucose (FPG and 2hPG) concentrations, fasting plasma glucose (FPG) concentration, smoking habits, systolic blood pressures, total cholesterol concentration, and BMI (Table 2 ). In particular the FPG and 2hPG concentrations have been grouped into four classes according to WHO recommendations [35] : (i) normal fasting glucose and normal glucose tolerance (FPG <6.1 mmol/l and mmol/l 2hPG <7.8 mmol/l); (ii) IGT and/or IFG (impaired glucose regulation which includes IGT and IFG, non-diabetic subjects with FPG ≥6.1 but <7.0 mmol/l and/or 2hPG ≥7.8 but <11.1 mmol/l); (iii) screened diabetes with FPG ≥7.0 mmol/l and/or 2hPG ≥11.1 mmol/l and no previous history of diabetes; and (iv) known diabetes (diabetes diagnosed before the baseline examinations). The glycaemic status according to the FPG concentration is also grouped into four categories: (i) normal fasting glucose (FPG <6.1 mmol/l); (ii) IFG (6.1≥FPG <7.0 mmol/l); (iii) screened diabetes (diagnosed by a fasting hyperglycaemia, FPG ≥7.0 mmol/l and no previous history of diabetes); and (iv) known diabetes (diagnosed before the baseline examinations).
The hazard ratios for cardiovascular mortality were estimated for men and women separately, using Cox proportional hazards models. All models were adjusted for age (in age categories) and for study centre to allow for the fact that the absolute risk varies from one population to another [11, 17, 18, 19, 20, 21, 22, 23, 24] . All factors were included as categories in the risk score to allow for possible non-linear effects of the factors and so that a risk score can be evaluated for a given individual by simply summing scores corresponding with the categories for each factor.
The hazard ratios associated with each factor were estimated, and then two multivariate models were determined including all factors, the first with categories for FPG and 2hPG and the second with only FPG categories, to correspond with the two situations where an OGTT is or is not available. The log likelihood ratio test was used to test whether the risk factors had significantly different effects in men and women, in multivariate models, with all factors included except BMI, which was not a significant predictor in multivariate models.
We gave a risk score for each category of each factor. These scores are the beta coefficients, from the Cox proportional hazards model, multiplied by 10 and rounded to the closest integer. For the two models, the first with FPG and 2hPG and the second with only FPG categories, the beta coefficients for the other parameters were almost identical, and for simplicity have been averaged in the final risk score. The risk score for an individual is obtained by summing the scores for the appropriate level of each of the risk factors. This simple, easily calculated score is a relative risk score for a given population.
To estimate an absolute risk of cardiovascular mortality, based on the 1995 mortality statistics, we used the Italian cohort from Milan as a reference group. This particular cohort was chosen because it included both men and women, and had subjects in all age categories studied. In this cohort the probability of a cardiovascular death is given by the Cox model by [1−S exp(R/10) ]: S is the survival probability, estimated for either the 5-or 10-year follow-up, and it is averaged over the two models, the first with FPG and 2hPG and the second with FPG alone; R is the risk score, calculated as above, for either the 5-or 10-year follow-up period. As cardiovascular disease mortality differs between countries, we use the WHO causes of death statistics to calibrate the absolute risk for other countries, with the assumption that the cardiovascular mortality experience in the Italian cohort in the DECODE Study is representative of the country as a whole. The 1995 mortality statistics available from the WHO web site [36] enabled us to determine a multiplying factor for country-specific cardiovascular disease mortality in relation to Italian cardiovascular disease mortality. We derived sex-specific multiplying factors (M) using the average value of the ratios of the 1995 cardiovascular mortality (ICD9 codes 401-448 [32] ), in 5-year age classes, in particular countries with respect to Italy, over the age range of 35 to 79 years. The complete equation for predicting death is then M[1−S exp(R/10) ].
SPSS for Windows 11.0 was used for statistical analysis. A p value of less than 0.05 was considered statistically significant, although exact p values are reported.
Results
We studied 16,506 men and 8,907 women aged 30 to 74 years (Table 1) ; four of the 14 studies only included men. The numbers of subjects in the individual cohorts were quite diverse, and the complete age range was covered in seven of the 14 studies. Almost half of the men and one-third of the women were under 50 years of age. Close to 70% of the population had normal glucose levels, 4% had known diabetes and 5% were screened as diabetic. Three of the studies did not include subjects who were known to have diabetes. For the other cardiovascular risk factors, in men almost 50% smoked, 20% had hypertension (systolic blood pressure ≥160 mm Hg), 20% had high cholesterol concentrations (≥7.0 mmol/l), and 13% were obese (BMI ≥30 kg/m 2 ). In women, 23% smoked, 16% had hypertension, 30% had high cholesterol and 21% were obese.
From the pooled cohort, 301 (1.8%) of the men and 56 (0.6%) of the women died from cardiovascular causes during 5 years of follow-up (Table 2) ; over 10 years, there were 632 (3.8%) and 159 (1.8%) cardiovascular deaths respectively.
Over 5 years, the risk of cardiovascular mortality differed between centres for the men, after adjusting for age class (Table 3) . Among the men, after adjusting for age and study centre, glucose concentrations, smoking, systolic blood pressure and cholesterol concentrations were significant predictors of 5-year cardiovascular mortality, but BMI was not a predictor. These factors all remained predictive when they were entered together into a multivariate model. In women, after age and centre adjustment, only glucose concentrations, systolic blood pressure and BMI were significant predictors of cardiovascular mortality; however, when all factors were entered into a model, only the glucose concentrations and age were predictive. There were significant differences in the effects on 5-year cardiovascular mortality between sex and age (p<0.005) and between sex and glucose concentrations (p<0.05 and p<0.005 for the FPG and 2hPG and the FPG categories respectively).
Over the 10-year period, after adjusting for age and centre, BMI was not predictive of cardiovascular mortality, either in men or in women. In both sexes, glucose concentrations, smoking and systolic blood pressure were predictive, whereas the cholesterol concentration also added to the prediction of fatal cardiovascular risk in men but not in women. These results did not change when all factors were entered into a multivariate model. Again, only the effects of age and glucose levels, whether by FPG and 2hPG or by FPG classes, differed between the sexes (p<0.001 for age, p<0.005 and p<0.005 for glucose categories respectively).
Sex-specific scores are given for age and for glucose concentrations, and the other scores are common for men and women (Table 4) . BMI has not been included in the final risk score as it was not a significant predictor of cardiovascular mortality in the multivariate models. From log likelihood ratio tests, the glucose factors improved the prediction (p<0.001) for cardiovascular disease when glucose was either in the form of FPG and 2hPG classes or as FPG classes, both in men and in women.
The sex-and country-specific multiplying factor (M) and the cumulated survival probabilities (S) are given in Table 5 to enable the calculation of the absolute risk of cardiovascular death within the given 5-or 10-year time periods: M×[1−S exp(R/10) ], using the risk score R.
As an example of using this risk score, we have estimated in Table 6 the 5-and 10-year risk of cardiovascular mortality for an Italian man and for an Italian woman aged 55 years, who smoked, had a systolic blood pressure of 145 mm Hg and a cholesterol concentration of 6.5 mmol/l according to different glucose categories. The 5-year risk for cardiovascular mortality was under 1%, except in the diabetic men. At 10 years of follow-up there was a gradual increase as the glucose intolerance worsened, which was especially marked in women.
Discussion
Results from the DECODE Study. While many of the cardiovascular risk scores have included diabetes, this is the first to include non-diabetic glucose concentrations. Glucose concentrations below the diabetic level had not been recognised as a risk factor for premature Cholesterol (mmol/l) <6.0 0 0 6.0-6.9 1 1 7.0-7.9 1 1 ≥8.0 9 6 * NFG & NGT, fasting plasma glucose <6.1 mmol/l and 2-h plasma glucose <7.8 mmol/l death. The DECODE cohort has demonstrated that high plasma glucose is an independent risk factor for cardiovascular diseases and mortality [25, 26, 31, 34] and this has been supported by other studies [29, 30] . The large DECODE database enabled risk scores to be estimated, and a score could be given for a 5-year follow-up of cardiovascular mortality, in men as well as in women, where the event rate was low. As expected, age was always the strongest risk factor for cardiovascular mortality. At both 5 and 10 years of follow-up of the DECODE cohort, glucose concentrations were always predictive of cardiovascular mortality. For the other risk factors studied, smoking was always predictive of mortality, except for the 5-year cardiovascular mortality in women, where the risk was a little lower, but not statistically different, compared with that in men (cardiovascular mortality hazard ratios for current smokers of 2.19 [95% CI: 1.54-3.10] for men and 1.72 [0.90-3.31] for women). Systolic blood pressure was always predictive of cardiovascular mortality, except over the 5-year period in women. For women, cholesterol was never predictive, but in men it was predictive at both 5 and 10 years. In fact, the effects of cholesterol and systolic blood pressure did not differ significantly between men and women. The lack of significant results in women is due to lack of power, as there were fewer cardiovascular deaths than in the men. In multivariate models, BMI was never predictive of cardiovascular mortality, although it came close in the women over 5 years of follow-up. Obesity has an impact through its association with the other risk factors.
The risk associated with the glucose concentrations was not just due to the diabetic subjects. Almost always, all of the hyperglycaemic classes had significantly higher risks than the reference group. Men with known diabetes had a two-fold higher cardiovascular mortality in comparison with the screened diabetic men, for both 5 and 10 years of follow-up; the cardiovascular risk in screened diabetic men was only slightly higher than that associated with the prediabetic classes. The hazard ratios for the diabetic or prediabetic states were much higher in the women than in the men, making the inclusion of glucose in a risk score very important for women. While the hazard ratios increased over the glucose classes, at 5 years, the risk was much higher for the women with known diabetes than for the women with screened diabetes, but at 10 years, the risks were almost identical. The risk scores indicate clearly that age and glucose concentrations (in particular diabetes) strongly predict cardiovascular mortality. It is of note that in women, the prediabetic states carry a similar cardiovascular risk to current smoking.
The hazard ratios associated with the risk factors decreased slightly as the length of follow-up increased, except in the case of systolic blood pressure.
As life expectancy and the risk of cardiovascular mortality differs between regions, countries and within countries, the risk score ranks individuals, within a given context. We also provide a method of obtaining an absolute risk score for a country, calibrated using the WHO mortality statistics.
Comparison with other risk scores. It may be inadvisable to compare the actual coefficients from the factors in the models derived from different studies, as these factors may intercorrelate differently in different populations. The aim of these risk score functions is to predict the risk, and it is of less importance to interpret the individual factors. However, one study has compared the individual hazard functions for coronary events in eight male populations, and five female populations [19] ; they found some similarities and some differences between ethnic groups for the major cardiovascular risk factors.
For the Framingham score [8] , the actual weights for each of the factor categories are similar to those in our study, but both total and HDL cholesterol are included in the Framingham model, and we are only able to include total cholesterol. Further, as we include glucose concentrations and the Framingham score does not, the two risk functions are not really comparable. Additionally, our score is for cardiovascular mortality, whereas the Framingham score is for coronary events.
Risk scores for cardiovascular, coronary, cerebrovascular and all-cause mortality were derived from a meta-analysis of 47,000 adults with raised blood pressure, treated in eight clinical trials [12] . Follow-up was from 2.0 to 6.9 years, with a mean follow-up of 5.2 years. The risk factors were used as continuous variables (age, cholesterol concentration, systolic blood pressure) in a Cox proportional hazards model. They found that these continuous factors were linear in predicting mortality, a result different from in the Framingham study [8] where for women, age was better modelled by both linear and squared terms. In the final risk score, these continuous variables were categorised to provide a score with integers which is easily calculable by a physician. Initially they used 16 risk factors, but as four were not significant in the multivariate models, 12 factors remained, and after investigating interactions among them, five significant interaction terms were retained in the cardiovascular model. With age there were significant three-way interactions with smoking and sex and there were two-way interactions between sex and each of diabetes, cholesterol concentrations and smoking status. In contrast, we found that only age and glucose concentrations had differing effects on cardiovascular mortality in men and women. This is in keeping with previous findings, with a lower risk in women than in men in middle age, but similar risks between the sexes in the elderly. Further, women who are diabetic lose their protective advantage as we have already shown in the DECODE Study [34] .
Another risk score comes from the PROCAM study [13] , but this is restricted to the 10-year risk of a myocardial infarction in men. This score includes both LDL and HDL cholesterol and triglycerides, but not total cholesterol or glucose concentrations.
The European SCORE project provides the most recent risk score [17] , a 10-year risk score for both coronary and non-coronary cardiovascular mortality based on the classic risk factors: sex, age, systolic blood pressure, smoking and either total cholesterol or total : HDL cholesterol. The use of the cardiovascular risk charts is recommended in the European Guidelines on Cardiovascular Disease and Prevention in Clinical Practice [1]. Diabetes was not included in the SCORE risk score because of lack of comparable data in the individual studies, but in the European recommendations, separate treatment thresholds are given for diabetic patients for both cholesterol and blood pressure.
The need to include other cardiovascular risk factors in the risk score has been investigated in the ARIC study [16] . They developed a predictive score using the basic risk factors smoking, diabetes, HDL cholesterol, total cholesterol, systolic blood pressure (including medication), and then investigated the merit of including various other risk factors, using as a criterion an increase in the area under the ROC curve to predict an incident event. Glucose concentrations were not studied. They concluded that there was no single risk factor (either a basic or a new risk factor) that "provided a large increase in predictivity" besides systolic blood pressure. When the 10-year predicted risks were compared between (i) the basic model with traditional risk factors and (ii) the model with all considered risk factors, there were more events predicted in the last decile group of the latter risk score, enabling high-risk subjects to be better identified.
The UKPDS risk engine has been developed for diabetic patients, for both coronary heart disease and for stroke [37, 38] . Some of the subjects included in the UKPDS had a FPG of only 6 mmol/l at inclusion, so are comparable to the hyperglycaemic subjects in our study. While the initial glucose levels were not used in this score, HbA 1 c was a significant risk factor for fatal and non-fatal myocardial infarction or sudden death, corroborating our results with subjects classified as screened diabetic and IFG or IGT.
Limitations of this study. Our study has a number of limitations. The first is that there was not a homogeneous protocol for data collection, and each centre measured both physical and laboratory measures according to their own protocols. Glucose was measured not only in different laboratories, but with differing assay methods and different forms of blood samples, but concentrations have been transformed so that they correspond with plasma glucose [34] . The cardiovascular endpoints are also likely to be affected by the individual centre and country practices of classification, despite the common use of the International Classification of Diseases [34, 35] . These study differences would all serve to lower the precision of the data, and so make our statistical results less significant than if a common standardised protocol had been used.
The 14 cohorts from which we draw our results are quite diverse. We studied the effect of the individual risk factors in each of the cohorts, and found that they had a consistent effect on cardiovascular mortality, but the relations were often not significant in individual cohorts because of their small size and limited number of events.
One limitation for the comparison of this score with scores developed from other studies is that we have no knowledge of whether the subjects already had cardiovascular disease at baseline. Usually the relations between risk factors and events are weaker after cardiovascular disease is manifest, so our results would tend to be less significant because of this. Most other scores have been based on subjects free of cardiovascular disease. An advantage is that our score can be applied to all subjects, regardless of their previous history of cardiovascular disease.
While we added a new factor, glucose concentrations, to this risk score, we are not able to include HDL cholesterol or triglyceride concentrations [8, 13] , or waist circumference or waist hip ratio [16] as these variables were not available for all of the DECODE cohorts. No doubt other risk scores, such as the risk score in the ARIC study [16] , will be developed to include parameters that have more recently been shown to be predictive of cardiovascular mortality, such as C-reactive protein, fibrinogen and other markers of inflammation, microalbuminuria and numerous other factors [39, 40, 41] .
Another limitation is that while all cohorts have a follow-up of almost 5 years, the 10-year follow-up is available in seven of the 14 cohorts, with 8 or more years in 11 of the 14 studies. These seven cohorts with a complete 10-year follow-up, provide 85% of the data in the men and 74% in the women. Further, two of the English cohorts, which total under 10% of the subjects in the study, did not include known diabetic subjects in their data collection.
Conclusions.
For diabetic patients, a recent article [42] indicated that such cardiovascular risk scores have a role in clinical practice. In an outpatients' clinic, the calculation of a risk score led to an increase in the prescription of risk-modifying drugs, but appropriately, only for the patients at higher risk. Glucose concentrations, whether we combine fasting and 2-h glucose concentrations or whether we use fasting glucose alone, play a role in predicting cardiovascular mortality in subjects with hyperglycaemia. In particular they have an important role in predicting the risk in wom-en. This score now needs to be validated in other populations.
